Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome
Abstract. Objective. Cryopyrin-associated periodic syndrome (CAPS) is a heterogeneous group of diseases characterized by excessive IL-1β release resulting in s
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2016
|
| In: |
Rheumatology
Year: 2015, Jahrgang: 55, Heft: 4, Pages: 689-696 |
| ISSN: | 1462-0332 |
| DOI: | 10.1093/rheumatology/kev416 |
| Online-Zugang: | Verlag, Volltext: https://doi.org/10.1093/rheumatology/kev416 Verlag, Volltext: https://academic.oup.com/rheumatology/article/55/4/689/1833374 
|
| Verfasserangaben: | Jasmin B. Kuemmerle-Deschner, Ferdinand Hofer, Theresa Endres, Birgit Kortus-Goetze, Norbert Blank, Elisabeth Weißbarth-Riedel, Catharina Schuetz, Tilmann Kallinich, Karoline Krause, Christoph Rietschel, Gerd Horneff and Susanne M. Benseler |
| Zusammenfassung: | Abstract. Objective. Cryopyrin-associated periodic syndrome (CAPS) is a heterogeneous group of diseases characterized by excessive IL-1β release resulting in s |
|---|---|
| Beschreibung: | Advance Access publication 14 December 2015 Gesehen am 22.11.2019 |
| Beschreibung: | Online Resource |
| ISSN: | 1462-0332 |
| DOI: | 10.1093/rheumatology/kev416 |